Home Cart 0 Sign in  
X

[ CAS No. 99584-48-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 99584-48-2
Chemical Structure| 99584-48-2
Chemical Structure| 99584-48-2
Structure of 99584-48-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 99584-48-2 ]

Related Doc. of [ 99584-48-2 ]

Alternatived Products of [ 99584-48-2 ]

Product Details of [ 99584-48-2 ]

CAS No. :99584-48-2 MDL No. :MFCD22548154
Formula : C3HCl2N3 Boiling Point : -
Linear Structure Formula :- InChI Key :DHFJTUKAWMNXNY-UHFFFAOYSA-N
M.W : 149.97 Pubchem ID :17909064
Synonyms :

Calculated chemistry of [ 99584-48-2 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 29.85
TPSA : 38.67 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.42 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.62
Log Po/w (XLOGP3) : 1.12
Log Po/w (WLOGP) : 1.18
Log Po/w (MLOGP) : 0.36
Log Po/w (SILICOS-IT) : 2.1
Consensus Log Po/w : 1.28

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.03
Solubility : 1.4 mg/ml ; 0.00932 mol/l
Class : Soluble
Log S (Ali) : -1.53
Solubility : 4.47 mg/ml ; 0.0298 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.49
Solubility : 0.482 mg/ml ; 0.00321 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.17

Safety of [ 99584-48-2 ]

Signal Word:Danger Class:8
Precautionary Statements:P264-P270-P280-P301+P312+P330-P305+P351+P338+P310-P501 UN#:1759
Hazard Statements:H302-H318 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 99584-48-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 99584-48-2 ]

[ 99584-48-2 ] Synthesis Path-Downstream   1~7

  • 2
  • [ 99584-48-2 ]
  • 2-(4-chloro-2-(methoxymethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane [ No CAS ]
  • C11H9Cl2N3O2 [ No CAS ]
YieldReaction ConditionsOperation in experiment
With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium carbonate In 1,4-dioxane; water
  • 3
  • [ 99584-48-2 ]
  • (3S,4S)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine bis-hydrochloride salt [ No CAS ]
  • (3S,4S)-8-(6-chloro-1,2,4-triazin-3-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine [ No CAS ]
YieldReaction ConditionsOperation in experiment
76.6% With N-ethyl-N,N-diisopropylamine In 1,4-dioxane at 50℃; for 3h; 1.A; 2.A; 29.A Step A: (3ri,,4ri,)-3-Methyl-2-oxa-8-azaspiro[4.5]decan-4-amine dihy drochloride (320 mg, 1.3 mmol) was diluted with dioxane (6 mL), f ollowed by the addition of DIEA (815 pL, 4.67 mmol) and 3,6-dichloro-l,2,4-triazine (200 mg, 1.33 mmol). The reaction was heated to 50 °C and stirred for 3 hours. The reaction was allowed to cool and diluted with DCM/IPA and 10% sodium carbonate. The layers were separated, and the aqueous was extracted twice with DCM/IPA. The organics were combined, dried over MgS0 , filtered and concentrated. The material was purified on silica gel eluting with 1-10% methanol/DCM (1% NH4OH) to afford (3k,4k)-8-(6-chloro- l , 2, 4-triazin-3-yl )-3 -methyl -2-oxa-8- azaspiro[4.5 Jdecan -4-amine (290 mg, 1.02 mmol, 76.6% yield).
  • 4
  • [ 99584-48-2 ]
  • [ 132234-69-6 ]
  • tert-butyl ((1R,3s,5S)-8-(6-chloro-1,2,4-triazin-3-yl)-8-azabicyclo[3.2.1]octan-3-yl)carbamate [ No CAS ]
YieldReaction ConditionsOperation in experiment
69.1% With N-ethyl-N,N-diisopropylamine In 1,4-dioxane at 50℃; for 3h; 3.A Step A: /erZ-Butyl ((li?,3s,5A)-8-azabicyclo[3.2.1]octan-3-yl)carbamate (226 mg, 1.00 mmol) was diluted with dioxane (5 mL), followed by the addition of DIEA (611 pL, 3.50 mmol) and 3,6-dichloro-l,2,4-triazine (150 mg, 1.00 mmol). The reaction was heated to 50 °C and stirred for 3 hours. The reaction was allowed to cool, diluted with DCM/IPA and 10% sodium carbonate. The layers were separated, and the aqueous was extracted twice with DCM/IPA. The organics were combined, dried over MgS0 , filtered and concentrated. The material was purified on silica gel eluting with 10-50% ethyl acetate/hexanes to afford tert- butyl ((li?,3s,5A)-8-(6-chloro-l,2,4-triazin-3-yl)-8-azabicyclo[3.2.1]octan-3-yl)carbamate (235 mg, 0.692 mmol, 69.1% yield).
  • 5
  • [ 99584-48-2 ]
  • (R)-N-((S)-1,3-dihydrospiro[indene-2,4‘-piperidin]-1-yl)-2-methylpropane-2-sulfinamide [ No CAS ]
  • (R)-N-((S)-1‘-(6-chloro-1,2,4-triazin-3-yl)-1,3-dihydrospiro[indene-2,4’-piperidin]-1-yl)-2-methylpropane-2-sulfinamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
11% With N-ethyl-N,N-diisopropylamine In 1,4-dioxane at 50℃; for 3h; 6.A Step A: (i?)-/V-((A)-l ,3-Dihydrospiro[indene-2,4'-piperidin]-l-yl)-2- methylpropane-2-sulfmamide(l 63 mg, 0.53 mmol) was diluted with dioxane (2 mL), followed by the addition of DIEA (326 pL, 1.9 mmol). After stirring for 5 minutes, 3,6-dichloro-l,2,4- triazine (80 mg, 0.53 mmol) was added. The reaction was heated to 50 °C and stirred for 3 hours. The reaction was allowed to cool and diluted with DCM/IPA and 10% sodium carb onate. The layers were separated, and the aqueous was extracted twice with DCM/IPA. The organics were combined, dried over MgS0 , filtered and concentrated. The material was purified on silica gel eluting with 1-10% methanol/DCM (l% NH OH) to afford (R)-N-((S)- '-(6-chloro- l ,2,4-triazin-3-yl)-l ,3-dihydrospiro[indene-2,4'-piperidin]-l -yl)-2-methylpropane-2- sulfinamide (25 mg, 0.060 mmol, 1 1 % yield).
  • 6
  • [ 99584-48-2 ]
  • 2-amino-3-chloropyridine-4-thiol sodium salt [ No CAS ]
  • tert-butyl (R)-5-(((R)-tert-butylsulfinyl)amino)-5,7-dihydrospiro[cyclopenta[b]pyridine-6,4’-piperidine]-1‘-carboxylate [ No CAS ]
  • (R)-N-((R)-1‘-(6-((2-amino-3-chloropyridin-4-yl)thio)-1,2,4-triazin-3-yl)-5,7-dihydrospiro[cyclopenta[b]pyridine-6,4’-piperidin]-5-yl)-2-methylpropane-2-sulfinamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
65% Stage #1: tert-butyl (R)-5-(((R)-tert-butylsulfinyl)amino)-5,7-dihydrospiro[cyclopenta[b]pyridine-6,4’-piperidine]-1‘-carboxylate With trifluoroacetic acid In dichloromethane for 1h; Stage #2: 3,6-dichloro-1,2,4-triazine With triethylamine In 1,4-dioxane at 50℃; for 3h; Stage #3: 2-amino-3-chloropyridine-4-thiol sodium salt In 1,4-dioxane at 90℃; for 18h; 16.A; 16.B Step A: fert-Butyl (f?)-5-(((f?)-fer/-butylsulfinyl)amino)-5,7- dihydrospiro[cyclopenta[A]pyridine-6,4'-piperidine]-l'-carboxylate (0.193 g, 0.474 mmol) was dissolved in DCM (3 mL), and then 2,2,2-trifluoroacetic acid (0.270 g, 2.37 mmol) was added. After stirring for 1 hour, reaction was evaporated, and the remaining TFA salt was used in the next step without further purification. Step B: (f?)-/V-((f?)-5,7-Dihydrospiro[cyclopenta[6]pyridine-6,4'-piperidin]-5- yl)-2-methylpropane-2-sulfmamide (0.07 g, 0.23 mmol) as TFA salt was dissolved in dioxane (4 mL), and TEA (0.16 mL, 1.1 mmol) was added to the solution. 3,6-Dichloro-l,2,4-triazine (0.032 g, 0.22 mmol) was added, and the mixture was heated up to 50 °C for 3 hours. Sodium 2-amino-3-chloropyridine-4-thiolate (0.050 g, 0.27 mmol) was added to the reaction mixture, and the mixture was heated up to 90 °C for 18 hours. The reaction was cooled down to room temperature, quenched with water (10 mL) and extracted with EtOAc (3 X 15 mL). The combined organic layers were washed with brine, dried and evaporated to give a residue. The residue was purified using 24 g silica gel column (MeOH/DCM mixture 2-20%) provided (R A-((i?)-r-(6-((2-amino-3-chloropyridin-4-yl)thio)-l,2,4-triazin-3-yl)-5,7- dihydrospiro[cyclopenta[6]pyridine-6,4'-piperidin]-5-yl)-2-methylpropane-2-sulfinamide (0.081 g, 0.15 mmol, 65% yield) as a solid m/z (esi/APCI) M+1 =545.2.
  • 7
  • [ 99584-48-2 ]
  • (R)-N-((S)-5,7-dihydrospiro[cyclopenta[b]pyridine-6,4’-piperidin]-5-yl)-2-methylpropane-2-sulfinamide [ No CAS ]
  • (R)-N-((S)-1‘-(6-chloro-1,2,4-triazin-3-yl)-5,7-dihydrospiro[cyclopenta[b]pyridine-6,4’-piperidin]-5-yl)-2-methylpropane-2-sulfinamide [ No CAS ]
YieldReaction ConditionsOperation in experiment
47% With triethylamine In 1,4-dioxane at 100℃; 24.B Step B: (/i)-A/-(C.y)-5,7-Dihydrospiro[cyclopenta[/>]pyridine-6,4'-piperidin]-5- yl)-2-methylpropane-2-sulfmamide (0.15 g, 0.49 mmol) and 3,6-dichloro-l,2,4-triazine (0.084 g, 0.56 mmol) were dissolved in 1 ,4-dioxane (1.5 mL, 0.375 mmol). Triethylamine (0.21 mL, 1.47 mmol) was added, and the resulting solution was stirred at 100 °C overnight. The crude material was loaded onto a 40g silica gel column and isolated over a gradient of 50- 100%EtO Ac/hexane to afford (R)-N-((S)- '-(6-chloro- l ,2,4-triazin-3-yl)-5,7- dihydrospiro[cyclopenta[Z>]pyridine-6,4'-piperidin]-5-yl)-2-methylpropane-2-sulfinamide (0.099 g, 0.23 mmol, 47% yield) as a solid m/z (esi/APCI) M+1 = 421.2.
Same Skeleton Products
Historical Records